Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02536950 · ClinicalTrials.gov registry record · NA
An Outpatient Study of Automated Blood Glucose Control With an Insulin-Only Bionic Pancreas
A NA study, sponsored by Bruce A. Buckingham.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT02536950: Completed NA study, sponsored by Bruce A. Buckingham.
NCT02536950 is a NA study that has completed, run by Bruce A. Buckingham. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02536950, a NA study, has completed, sponsored by Bruce A. Buckingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
This is an open-label, non-randomized, pilot study to determine the safety and feasibility of the insulin-only bionic pancreas.
Primary Outcome
Dexcom G4P AP mean glucose
Interventions
- DEVICE Fixed set point
- DEVICE Variable set point
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2015-08 |
| Est. Completion | 2016-07 |
| Phase | NA |
What the finished NCT02536950 record still lists
NCT02536950 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Fixed set point is the first listed.
NCT02536950 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02536950 about?
NCT02536950 is a clinical study titled "An Outpatient Study of Automated Blood Glucose Control With an Insulin-Only Bionic Pancreas". This is an open-label, non-randomized, pilot study to determine the safety and feasibility of the insulin-only bionic pancreas.
What is the current status of trial NCT02536950?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2015-08. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02536950?
The interventions under investigation include: Fixed set point (DEVICE), Variable set point (DEVICE).
Who is sponsoring clinical trial NCT02536950?
This trial is sponsored by Bruce A. Buckingham, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02536950's enrollment target sits among peer trials
16 1871st of 2000 higher than 120 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia